Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18348657)

  • 1. Invasive cribriform breast carcinomas in patients with grade 1 and stage IIA (T2 N0 M0) breast cancer strongly express the v3 and v6, but not the v4 isoforms of the metastatic marker CD44.
    Saleh F; Reno W
    Neoplasma; 2008; 55(3):246-55. PubMed ID: 18348657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
    Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF
    Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
    Satoh K; Shimosegawa T; Koizumi M; Toyota T
    Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of CD44 molecule in renal cell carcinoma.
    Lucin K; Matusan K; Dordević G; Stipić D
    Croat Med J; 2004 Dec; 45(6):703-8. PubMed ID: 15578803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?
    Regauer S; Ott A; Berghold A; Beham A
    J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.
    Masuda M; Takano Y; Iki M; Makiyama K; Noguchi S; Hosaka M
    J Urol; 1999 Mar; 161(3):805-8; discussion 808-9. PubMed ID: 10022688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CD44 isoform expression in thymic epithelial neoplasms.
    Sonobe S; Miyamoto H; Nobukawa B; Izumi H; Futagawa T; Ishikawa N; Yamazaki A; Uekusa T; Abe H; Suda K
    Cancer; 2005 May; 103(10):2015-22. PubMed ID: 15830350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification and grading of invasive breast carcinoma.
    Elston CW
    Verh Dtsch Ges Pathol; 2005; 89():35-44. PubMed ID: 18035670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are CD44 variant isoforms involved in human tumour progression?
    Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
    Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of CD44v3 expression in female breast carcinomas.
    Ryś J; Kruczak A; Lackowska B; Jaszcz-Gruchała A; Brandys A; Stelmach A; Reinfuss M
    Pol J Pathol; 2003; 54(4):243-7. PubMed ID: 14998292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotyping analysis in invasive micropapillary carcinoma of the breast: role of CD24 and CD44 isoforms expression.
    Simonetti S; Terracciano L; Zlobec I; Kilic E; Stasio L; Quarto M; Pettinato G; Insabato L
    Breast; 2012 Apr; 21(2):165-70. PubMed ID: 22014860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CD44 variant 6 in human endometrial cancer and its prognostic significance.
    Ayhan A; Tok EC; Bildirici I; Ayhan A
    Gynecol Oncol; 2001 Mar; 80(3):355-8. PubMed ID: 11263931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
    Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
    Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation.
    Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J
    Int J Cancer; 1996 Jun; 69(3):218-24. PubMed ID: 8682591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
    Chuang CK; Liao SK
    Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BigH3 protein expression as a marker for breast cancer.
    Calaf GM; Echiburú-Chau C; Zhao YL; Hei TK
    Int J Mol Med; 2008 May; 21(5):561-8. PubMed ID: 18425347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of metallothionein predicts chemoresistance in breast cancer.
    Yap X; Tan HY; Huang J; Lai Y; Yip GW; Tan PH; Bay BH
    J Pathol; 2009 Mar; 217(4):563-70. PubMed ID: 19116991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
    Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.